個股熱度排行 | 1月12日美股盤前
根據uSMART輿情監測數據，從11日晚間到12日美股盤前時間段，中國投資者關注指數最高的5只股票是京東、阿裏巴巴、花旗銀行、摩根大通集團、瑞銀。
1月12日—美股關注排行TOP5
京東
關注度第一爲京東，該股上個交易日收盤上漲10.29%，報於76.76美元。近5個交易日累計上漲19.56%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
Atlantic Equities首次覆蓋京東：予以“增持”評級，目標價100美元
野村下調京東目標價至348元 評級「買入」
阿裏巴巴
關注度第二爲阿裏巴巴，該股上個交易日收盤上漲3.03%，報於132.19美元。近5個交易日累計上漲10.56%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
恆指升502點; 恆生科技指數升216點 美團升逾9% 阿裏巴巴升逾4% 友邦升逾3% 匯控創新高
阿裏巴巴-SW漲5.73% 花旗維持其“買入”評級
花旗銀行
關注度第三爲花旗銀行，該股上個交易日收盤上漲1.64%，報於67.11美元。近5個交易日累計上漲5.54%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
花旗予英特爾“中性”評級 大摩上調特斯拉目標價至1300美元
花旗：周大福估值具吸引力 目標價20.7港元
摩根大通集團
關注度第四爲摩根大通集團，該股上個交易日收盤上漲0.10%，報於167.49美元。近5個交易日累計下跌0.20%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
亞盛醫藥精彩亮相第40屆摩根大通醫療健康年會，向Biopharma穩步邁進
昭衍新藥被摩根大通減持42.5053萬股
瑞銀
關注度第五爲瑞銀，該股上個交易日收盤上漲0.62%，報於19.36美元。近5個交易日累計上漲3.97%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
瑞銀引述廣汽料今年產銷增長逾15% 估與本田及豐田合營將加快電動車貢獻
招商銀行獲瑞銀增持155.8萬股
此外，監測期內有1只股票的輿情出現大扭轉，意味着在消息面上出現了可能影響公司股價趨勢的事件或者轉折。
1月12日—美股輿情轉折預警
阿裏巴巴
阿裏巴巴輿情扭轉指數達100，目前輿情方向爲利好，表明公司出現了被投資者視作較大利好的消息。
其中較被市場關注的消息有：
恆指升502點; 恆生科技指數升216點 美團升逾9% 阿裏巴巴升逾4% 友邦升逾3% 匯控創新高
阿裏巴巴-SW漲5.73% 花旗維持其“買入”評級
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
